Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

Clinical trial NCT03608618 · TERMINATED

Trial details

NCT number: NCT03608618
Sponsor: MaxCyte, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Peritoneal Mesothelioma Fallopian Tube Adenocarcinoma Adenocarcinoma of the Ovary Primary Peritoneal Carcinoma

Start date: 2018-08-27
Primary completion: 2021-02-11
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.